• Enlitic

  Participated · Series B · Oct 2015

  Enlitic develops a medical deep learning platform that leverages practicing radiologists, data scientists, and software engineers to analyze large streams of healthcare data. The platform ingests millions of clinical cases from cross-sector healthcare partners to improve diagnostic accuracy and speed. Enlitic positions its technology to improve patient outcomes and to accelerate pharmaceutical research and drug trials. The company operates from offices in San Francisco, New York and Sydney. Leadership includes CEO Kevin Lyman and CMO Anthony Upton. It intends to use new funding to continue building out its AI software platform and to grow its global presence with major regional healthcare partners. Enlitic uses deep learning and other forms of artificial intelligence to develop algorithms that identify and analyze suspicious findings in medical images. The company has built a comprehensive platform that enables development, validation, and integration of clinical AI at scale, working closely with hospitals and radiology providers worldwide. Its first product interprets chest x-rays, triaging normal from abnormal scans and detecting and characterizing more than 40 distinct abnormalities such as cardiomegaly, lung nodules, and pneumothorax. Enlitic plans to use new funding to enhance its AI product portfolio and expand its engineering and data-scientist teams. The company is also focusing on obtaining regulatory approval for clinical use in the US, Australia, Japan, Europe, Canada, and Brazil. Enlitic is led by CEO Kevin Lyman and Chief Medical Officer Dr. Anthony Upton. Enlitic is a San Francisco-based deep learning company dedicated to improving diagnostic healthcare, led by CEO and data scientist Jeremy Howard. Its core product is a suite of deep-learning diagnostic tools commercially integrated end-to-end across a wide range of ailments, from lung cancer to bone fractures. Those tools are deployed to support radiologists’ workflows and are expected to power hundreds of radiologists across Capitol Health’s care network. Enlitic leverages Capitol Health’s image archives across multiple modalities (Ultrasound, CT, MRI, PET, X-Ray) to accelerate training of algorithms and to support diagnosis of thousands of diseases and afflictions. The company plans to expand the platform’s use cases and to map the entire human body and its afflictions. It will use the new funding to advance those efforts and to broaden deployment in partnered markets. Enlitic is a San Francisco, CA-based diagnostic healthcare company that uses machine learning to improve medical diagnostics. The company develops tools for physicians that can ingest and analyze medical images, doctors' notes, and structured lab tests to make diagnoses faster and more accurate. Led by founder and CEO Jeremy Howard, Enlitic aims to make diagnostics more accessible by leveraging advances in machine learning across different data types. Financially, Enlitic raised $2M in a funding round led by Amplify Partners with participation from Data Collective. The company is hiring, indicating growth or product development momentum. The article does not disclose operating metrics such as revenue or user counts.

• Bright Funds

  Participated · Equity · Jun 2015

  Bright Funds provides a Software-as-a-Service platform that connects employees to causes and enables personalized giving portfolios of individual nonprofits or curated funds focused on issues like poverty, education and the environment. The enterprise platform integrates with payroll and HRIS systems to automate vetting nonprofits, managing employee contributions, company matching, issuing payments to charities, and organizing and tracking volunteering. The service supports US and international giving, high-impact disaster relief, robust reporting, and tools for employees to track the progress and impact of their giving. Led by CEO Ty Walrod, Bright Funds currently serves over 30,000 people at more than 25 companies. The company plans to use the new capital to expand marketing and sales, enhance enterprise platform features, and hire staff in key areas as its customer base scales. Bright Funds offers a platform that bundles groups of 10–15 vetted nonprofits into themed “mutual funds,” letting users build personalized giving portfolios across causes. At launch it focuses on four areas—poverty relief, water, education and the environment—and allows donors to allocate dollars across facets or pick individual nonprofits. The company curated an initial set of roughly 50 nonprofits using research from GiveWell, Charity Navigator, Philanthropedia and the American Institute of Philanthropy. Donors can give one‑time or recurring amounts, receive tax‑deductible receipts, and use one‑click tax reporting; accounts are free to open and maintain. Bright Funds charges nonprofits a 7.5% fundraising fee to cover processing and transaction costs. Product features include a streaming feed for nonprofits to report outcomes, social sharing, and an employer-facing payroll integration; the startup plans to add bank‑account payment support in the coming months and two additional funds plus new nonprofits beginning in 2013.

• Asseta

  Participated · Seed · Mar 2015

  Asseta operates a B2B marketplace that connects manufacturers, dealers, and brokers to buy and sell spare parts and capital equipment. After launching with a focus on used manufacturing equipment, the company shifted to spare parts to increase transaction frequency. CEO Anton Brevde says the move grew transactions from 1–4 deals per year to 20–40 per month and the company has grown roughly 20% per month since. Buyers on the platform can save about 60% on spare part spending while Asseta charges a 10% transaction fee. The company plans to return to used capital equipment sales in the future and expand into other verticals, but is currently focused solely on parts. Asseta operates an online marketplace that lets sellers list used manufacturing equipment (make, model, year, description) and offers on-site photography, payment processing, shipping, and fulfillment. The company takes a 5–10% transaction fee, which it says is substantially lower than the industry broker norm of around 50%. Asseta launched its marketplace last August and is a Y Combinator summer 2013 alum; three of four founders have manufacturing backgrounds and Anton Brevde is CEO. The startup has added over 200,000 listings and reports 50% month-over-month growth, though the founders declined to disclose transaction counts or revenue. Asseta is pursuing a vertical-by-vertical expansion, starting with semiconductor equipment, then moving to other high-tech industries and eventually all used industrial equipment. The new funding will be used primarily to grow engineering and sales teams.

No current team members are available.